PHARMACY & PHARMACOLOGY (PHARM) -> PHARM - Lung Abstracts

511 - Evaluation of Universal versus Preemptive Antifungal Prophylaxis in Lung Transplantation

Presentation Number
511
Speakers
Session Name
MINI ORAL 14 - MINI ORAL SESSION: Pharmacy and Pharmacology
Date
Thu, Apr 23, 2020
Time
06:15 PM - 07:15 PM
Authors
Audio Upload

Previous ePresentation
489 - Clinical Outcomes after Pediatric Lung Transplantation at Cystic Fibrosis Care Centers

Next ePresentations
516 - Measuring and Monitoring Equity in Access to Deceased Donor Lung Transplants among Waitlisted Candidates
519 - Initial Successful Clinical Transplantation Using Negative Pressure Ventilation Ex-Situ Lung Perfusion with Extended Criteria Donor Lungs
521 - Low Lung Allocation Score Predicts Poor Waitlist Outcomes for Patients on Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation
747 - Fungal Prophylaxis and Chronic Lung Allograft Dysfunction
748 - Transition from BOS to RAS Impairs Prognosis after Lung Transplantation - CLAD Subtype Analysis by CT-Volumetry
749 - Outcomes of Single vs. Bilateral Lung Transplant in Patients with Chronic Obstructive Pulmonary Disease
755 - Significance of Phenotype Change Post CLAD-Onset on Allograft Survival
757 - Extracorporeal Photopheresis in Lung Transplantation
760 - Lung Transplantation Outcomes in Lymphangioleiomyomatosis
761 - Native Lung Complications after Living-Donor Lobar Lung Transplantation